1. Antimüllerian hormone levels decrease in women using combined contraception independently of administration route 
Sanna Kallio, M.D., Johanna Puurunen, M.D., Aimo Ruokonen, M.D., Ph.D., Tommi Vaskivuo, M.D., Ph.D., Terhi Piltonen, M.D., Ph.D., Juha S. Tapanainen, M.D., Ph.D. 
Fertility and Sterility 
Volume 99, Issue 5, Pages (April 2013)
DOI: /j.fertnstert
Copyright © 2013 American Society for Reproductive Medicine Terms and Conditions

2. Figure 1
Serum antimüllerian hormone (AMH) levels at baseline and after 5 and 9 weeks of administration of combined contraceptives by three different routes (oral [Pill], transdermal [Patch], and vaginal [Ring]). *P=.001 vs. baseline.
Fertility and Sterility  , DOI: ( /j.fertnstert )
Copyright © 2013 American Society for Reproductive Medicine Terms and Conditions

3. Figure 2
Serum inhibin B levels at baseline and after 5 and 9 weeks of administration of combined contraceptives by three different routes (oral [Pill], transdermal [Patch], and vaginal [Ring]). *P<.001 vs. baseline.
Fertility and Sterility  , DOI: ( /j.fertnstert )
Copyright © 2013 American Society for Reproductive Medicine Terms and Conditions

4. Figure 3
Effect of FSH on follicular growth and antimüllerian hormone (AMH) secretion in the ovary without (A) and during the use of combined contraception (B). Combined contraceptives reduce the effect of FSH and thus inhibit the growth of follicles, mainly in the antral stage. Reduced granulosa cell (GC) mass of the follicles results in a significant decrease in AMH secretion, mainly in antral follicles, but perhaps to some extent also in follicles at preceding stages.
Fertility and Sterility  , DOI: ( /j.fertnstert )
Copyright © 2013 American Society for Reproductive Medicine Terms and Conditions